ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta

43.00
-0.25 (-0.58%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -0.58% 43.00 42.00 44.00 44.00 42.50 43.25 797,907 16:16:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 23.25M -24.95M -0.0695 -6.19 155.29M
Avacta is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 43.25p. Over the last year, Avacta shares have traded in a share price range of 39.75p to 139.00p.

Avacta currently has 359,042,104 shares in issue. The market capitalisation of Avacta is £155.29 million. Avacta has a price to earnings ratio (PE ratio) of -6.19.

Avacta Share Discussion Threads

Showing 80676 to 80696 of 81050 messages
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older
DateSubjectAuthorDiscuss
03/10/2024
13:45
Shorters closing ?
fieldhouse
03/10/2024
13:26
Picking up now
robers98
03/10/2024
13:21
60p then 70. TOO CHEAP HERE
gkace
03/10/2024
10:54
Hahaha go and drain yourself you sap ;)
g2theary
03/10/2024
10:27
Get in VAST then same there but there's a better chance of a substantial rise ;) I've picked a few here technical bounce but this moves when it gets going ;)
g2theary
03/10/2024
09:27
back to 60p
gkace
03/10/2024
06:36
I've followed this company for years and nothing I repeat nothing has ever come fruitful with promises and waffle, and it begs the question will it ever me personally I doubt it, ok for a daily trade, shame they really have had some good stories over the years lol, this time next year rodders, the ramps are getting tiresome like stuck record if you know what one is, the Nas listing's especially lol how many times we hear that old chestnut, oh and the being bought out, oh lord
repins1
03/10/2024
06:13
I don't post to make pp eeps ' throw in the towel' but to save them from financial ruin. Seen so many spout, crumble and disappear, 9/10 with small Aim cos. Aim chief execs looks after themselves ultimately, are on the Grift.The reg framework is weak - need X4 yearly accounting reports.It.s corrupt.GL Cheshire.
amanitaangelicus
03/10/2024
06:09
I don't post to make pp eeps ' throw in the towel' but to save them from financial ruin. Seen so many spout, crumble and disappear, 9/10 with small Aim cos. Aim chief execs looks after themselves ultimately, are on the Grift.The reg framework is weak - need X4 yearly accounting reports.It.s corrupt.GL Cheshire.
amanitaangelicus
02/10/2024
19:31
Yeah yeah, keep trying guys you'll get a few to throw in the towel and sell up. Not me though, here till take out whenever.
cheshire pete
02/10/2024
16:51
The fact this is still such a long way from FDA approval with all the risks that involves and time it will take etc mean more fund raises are inevitable . Sadly like so many others that will be to shareholders detriment . Ava6000 might well be a great development but until it's a lot closer to approval I don't see any reason to buy here and the market cap looks very high given the risks and funding issues that will come down the line .
I've looked several times and simply don't get the optimism at this stage having seen so many other biotechs get hammered due to funding

bones698
02/10/2024
12:59
Turner Pope note out
robers98
02/10/2024
12:44
Found some support though. Good.
amanitaangelicus
02/10/2024
12:16
Considering how long the Phase 1a trial has been running that could be a long running series, you'd need lots of coffee to get through it.
1347
02/10/2024
09:44
fieldhouse - Avacta can only make money from AVA6000 one way and that's if it turns the whole sorrowful story into a Netflix series.
pwhite73
02/10/2024
09:30
Myles pump is slowly dying
bladderman
02/10/2024
08:04
Going forward , my guess is to licence a modified Ava6000 for use with dox.Hopefully funding phase 2 .
The platform will be evaluated by the scientific team of eminent cardiologists.
Numerous drugs will be evaluated on behalf of BP with additional licence fees .
In the meantime,to overcome the undoubted cash requirement,the DX division will be sold.
What we don’t know is how interested big pharma is and what value they put on the Ava at research .
Unknown,unknowns I am afraid.



overcome the undoubted cash hurdle ,the sale of the DX division.

fieldhouse
02/10/2024
07:50
Aman is a yellow-bellied two faced coward who jumps from one position to another like a flea with hindsight.
pwhite73
02/10/2024
07:40
I think Aman has been vindicated with his views
fieldhouse
02/10/2024
07:37
Owatfun,
Have you not listened to the interviews and results presentation ?

Cash runway is the problem and 2027 as a possible date for big data release from phase 2

fieldhouse
02/10/2024
07:14
Not the selling off etc ...
amanitaangelicus
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older

Your Recent History

Delayed Upgrade Clock